Drug Discovery

6 researchers across 1 institution

6 Researchers
1 Institutions
0 Grant PIs
0 High Impact

This research area investigates the identification, design, and development of new therapeutic agents. Investigations focus on understanding disease mechanisms at a molecular level to pinpoint potential drug targets. Researchers employ a range of techniques, including synthetic chemistry, medicinal chemistry, and biological assays, to create and evaluate novel compounds. Specific interests include developing inhibitors and degraders for key proteins involved in disease, exploring structure-activity relationships to optimize drug efficacy and safety, and utilizing computational methods to accelerate the discovery process.

Research in drug discovery holds significant relevance for Arkansas. It contributes to the state's growing biotechnology and pharmaceutical sectors, fostering economic development and creating high-skill jobs. Furthermore, this work directly addresses public health needs by seeking new treatments for prevalent diseases, potentially improving patient outcomes and reducing healthcare burdens within the state. The exploration of natural products, a rich resource in Arkansas, also offers opportunities for novel therapeutic discoveries.

This field draws upon expertise from diverse disciplines, including molecular biology, pharmacology, biochemistry, and computational science. Collaborative efforts extend across multiple institutions within Arkansas, fostering a comprehensive approach to tackling complex challenges in drug development.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Jaideep B. Bharate UAMS 16 757
Anupreet Kharbanda UAMS 12 434
Phuc Tran UAMS 6 148
Baha’a Jabali UAMS 4 106
Edward Zhao UAMS 2 31
Erica Lane Smith UAMS 2 42

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
5,395 works in 2025
+0.6% CAGR 2018–2025
Leadership concentration
7.0% held by global top 5 institutions
Fragmented HHI 26
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 3,562
  2. 2 Harvard University 2,965
  3. 3 National Cancer Institute 2,503
  4. 4 National Institutes of Health 1,945
  5. 5 Dana-Farber Cancer Institute 1,741
Browse All 6 Researchers in Directory